Cetera Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
KIM
SIA
AIA
NIM
FHA
1CP
Cetera Investment Advisers's HQL Position: Q4 2024 in Review
Cetera Investment Advisers sold out of abrdn Life Sciences Investors (HQL) in Q4 2024, closing a stake of 171,428 shares — an estimated $2.59M sold.
Cetera Investment Advisers first reported a position in HQL in Q4 2020 and held it in 16 quarters. The position peaked at $2.9M in Q2 2021. 72 funds tracked by Wall St. Rank hold HQL as of Q4 2024.
- Cetera Investment Advisers reported no remaining abrdn Life Sciences Investors position as of Q4 2024 after selling out during the quarter.
- Cetera Investment Advisers sold 171,428 abrdn Life Sciences Investors shares in Q4 2024, an estimated $2.59M.
- Cetera Investment Advisers first reported a position in abrdn Life Sciences Investors in Q4 2020 and held it in 16 quarters.
- Cetera Investment Advisers's abrdn Life Sciences Investors position peaked at $2.9M in Q2 2021.
- 72 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2024.
Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.